|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goral V: Pancreatic cancer: Pathogenesis
and diagnosis. Asian Pac J Cancer Prev. 16:5619–5624. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Matsuno S, Egawa S, Fukuyama S, Motoi F,
Sunamura M, Isaji S, Imaizumi T, Okada S, Kato H, Suda K, et al:
Pancreatic Cancer Registry in Japan: 20 years of experience.
Pancreas. 28:219–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ullrich O, Reinsch S, Urbé S, Zerial M and
Parton RG: Rab11 regulates recycling through the pericentriolar
recycling endosome. J Cell Biol. 135:913–924. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilcke M, Johannes L, Galli T, Mayau V,
Goud B and Salamero J: Rab11 regulates the compartmentalization of
early endosomes required for efficient transport from early
endosomes to the trans-golgi network. J Cell Biol. 151:1207–1220.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Riggs B, Rothwell W, Mische S, Hickson GR,
Matheson J, Hays TS, Gould GW and Sullivan W: Actin cytoskeleton
remodeling during early Drosophila furrow formation requires
recycling endosomal components Nuclear-fallout and Rab11. J Cell
Biol. 163:143–154. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Junutula JR, Schonteich E, Wilson GM,
Peden AA, Scheller RH and Prekeris R: Molecular characterization of
Rab11 interactions with members of the family of Rab11-interacting
proteins. J Biol Chem. 279:33430–33437. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Horgan CP and McCaffrey MW: The dynamic
Rab11-FIPs. Biochem Soc Trans. 37:1032–1036. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hales CM, Griner R, Hobdy-Henderson KC,
Dorn MC, Hardy D, Kumar R, Navarre J, Chan EK, Lapierre LA and
Goldenring JR: Identification and characterization of a family of
Rab11-interacting proteins. J Biol Chem. 276:39067–39075. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fielding AB, Schonteich E, Matheson J,
Wilson G, Yu X, Hickson GR, Srivastava S, Baldwin SA, Prekeris R
and Gould GW: Rab11-FIP3 and FIP4 interact with Arf6 and the
exocyst to control membrane traffic in cytokinesis. EMBO J.
24:3389–3399. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Muto A, Aoki Y and Watanabe S: Mouse
Rab11-FIP4 regulates proliferation and differentiation of retinal
progenitors in a Rab11-independent manner. Dev Dyn. 236:214–225.
2007. View Article : Google Scholar
|
|
12
|
Muto A, Arai K and Watanabe S: Rab11-FIP4
is predominantly expressed in neural tissues and involved in
proliferation as well as in differentiation during zebrafish
retinal development. Dev Biol. 292:90–102. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoon SO, Shin S and Mercurio AM: Hypoxia
stimulates carcinoma invasion by stabilizing microtubules and
promoting the Rab11 trafficking of the alpha6beta4 integrin. Cancer
Res. 65:2761–2769. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu F, Deng X, Yang X, Jin H, Gu D, Lv X,
Wang C, Zhang Y, Huo X, Shen Q, et al: Hypoxia upregulates
Rab11-family interacting protein 4 through HIF-1α to promote the
metastasis of hepatocellular carcinoma. Oncogene. 34:6007–6017.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chaika NV, Gebregiworgis T, Lewallen ME,
Purohit V, Radhakrishnan P, Liu X, Zhang B, Mehla K, Brown RB,
Caffrey T, et al: MUC1 mucin stabilizes and activates
hypoxia-inducible factor 1 alpha to regulate metabolism in
pancreatic cancer. Proc Natl Acad Sci USA. 109:13787–13792. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ye LY, Zhang Q, Bai XL, Pankaj P, Hu QD
and Liang TB: Hypoxia-inducible factor 1α expression and its
clinical significance in pancreatic cancer: A meta-analysis.
Pancreatology. 14:391–397. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hao XP, Willis JE, Pretlow TG, Rao JS,
MacLennan GT, Talbot IC and Pretlow TP: Loss of fragile histidine
triad expression in colorectal carcinomas and premalignant lesions.
Cancer Res. 60:18–21. 2000.PubMed/NCBI
|
|
18
|
Xue Z, Zhou Y, Wang C, Zheng J, Zhang P,
Zhou L, Wu L, Shan Y, Ye M, He Y, et al: Latexin exhibits
tumor-suppressor potential in pancreatic ductal adenocarcinoma.
Oncol Rep. 35:50–58. 2016.
|
|
19
|
Cong L and Zhang F: Genome engineering
using CRISPR-Cas9 system. Methods Mol Biol. 1239:197–217. 2015.
View Article : Google Scholar
|
|
20
|
Zhou Y, Zhu S, Cai C, Yuan P, Li C, Huang
Y and Wei W: High-throughput screening of a CRISPR/Cas9 library for
functional genomics in human cells. Nature. 509:487–491. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shalem O, Sanjana NE, Hartenian E, Shi X,
Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG, et
al: Genome-scale CRISPR-Cas9 knockout screening in human cells.
Science. 343:84–87. 2014. View Article : Google Scholar :
|
|
22
|
Hsu PD, Lander ES and Zhang F: Development
and applications of CRISPR-Cas9 for genome engineering. Cell.
157:1262–1278. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rachagani S, Macha MA, Heimann N,
Seshacharyulu P, Haridas D, Chugh S and Batra SK: Clinical
implications of miRNAs in the pathogenesis, diagnosis and therapy
of pancreatic cancer. Adv Drug Deliv Rev. 81:16–33. 2015.
View Article : Google Scholar :
|
|
24
|
Shahrokni A and Saif MW: Metastatic
pancreatic cancer: The dilemma of quality vs. quantity of life.
JOP. 14:391–394. 2013.PubMed/NCBI
|
|
25
|
Horgan CP, Hanscom SR, Kelly EE and
McCaffrey MW: Tumor susceptibility gene 101 (TSG101) is a novel
binding-partner for the class II Rab11-FIPs. PLoS One.
7:e320302012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cheng H, Sugiura R, Wu W, Fujita M, Lu Y,
Sio SO, Kawai R, Takegawa K, Shuntoh H and Kuno T: Role of the Rab
GTP-binding protein Ypt3 in the fission yeast exocytic pathway and
its connection to calcineurin function. Mol Biol Cell.
13:2963–2976. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Krzyzaniak MA, Mach M and Britt WJ:
HCMV-encoded glycoprotein M (UL100) interacts with Rab11 effector
protein FIP4. Traffic. 10:1439–1457. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wallace DM, Lindsay AJ, Hendrick AG and
McCaffrey MW: Rab11-FIP4 interacts with Rab11 in a GTP-dependent
manner and its overexpression condenses the Rab11 positive
compartment in HeLa cells. Biochem Biophys Res Commun. 299:770–779.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu CL, Wang JZ, Xia XP, Pan CW, Shao XX,
Xia SL, Yang SX and Zheng B: Rab11-FIP2 promotes colorectal cancer
migration and invasion by regulating PI3K/AKT/MMP7 signaling
pathway. Biochem Biophys Res Commun. 470:397–404. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang J, Liu X, Datta A, Govindarajan K,
Tam WL, Han J, George J, Wong C, Ramnarayanan K, Phua TY, et al:
RCP is a human breast cancer-promoting gene with Ras-activating
function. J Clin Invest. 119:2171–2183. 2009.PubMed/NCBI
|
|
31
|
Jing J, Tarbutton E, Wilson G and Prekeris
R: Rab11-FIP3 is a Rab11-binding protein that regulates breast
cancer cell motility by modulating the actin cytoskeleton. Eur J
Cell Biol. 88:325–341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dong W, Qin G and Shen R: Rab11-FIP2
promotes the metastasis of gastric cancer cells. Int J Cancer.
138:1680–1688. 2016. View Article : Google Scholar
|
